204 related articles for article (PubMed ID: 19225872)
1. Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.
Borgman MP; Ray A; Kolhatkar RB; Sausville EA; Burger AM; Ghandehari H
Pharm Res; 2009 Jun; 26(6):1407-18. PubMed ID: 19225872
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery.
Borgman MP; Aras O; Geyser-Stoops S; Sausville EA; Ghandehari H
Mol Pharm; 2009; 6(6):1836-47. PubMed ID: 19743884
[TBL] [Abstract][Full Text] [Related]
3. Anticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapy.
Greish K; Ray A; Bauer H; Larson N; Malugin A; Pike D; Haider M; Ghandehari H
J Control Release; 2011 May; 151(3):263-70. PubMed ID: 21223983
[TBL] [Abstract][Full Text] [Related]
4. Influence of the structure of drug moieties on the in vitro efficacy of HPMA copolymer-geldanamycin derivative conjugates.
Kasuya Y; Lu ZR; Kopecková P; Tabibi SE; Kopecek J
Pharm Res; 2002 Feb; 19(2):115-23. PubMed ID: 11883637
[TBL] [Abstract][Full Text] [Related]
5. HPMA copolymer-aminohexylgeldanamycin conjugates targeting cell surface expressed GRP78 in prostate cancer.
Larson N; Ray A; Malugin A; Pike DB; Ghandehari H
Pharm Res; 2010 Dec; 27(12):2683-93. PubMed ID: 20845065
[TBL] [Abstract][Full Text] [Related]
6. Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates.
Line BR; Mitra A; Nan A; Ghandehari H
J Nucl Med; 2005 Sep; 46(9):1552-60. PubMed ID: 16157540
[TBL] [Abstract][Full Text] [Related]
7. Comparison of active and passive targeting of docetaxel for prostate cancer therapy by HPMA copolymer-RGDfK conjugates.
Ray A; Larson N; Pike DB; Grüner M; Naik S; Bauer H; Malugin A; Greish K; Ghandehari H
Mol Pharm; 2011 Aug; 8(4):1090-9. PubMed ID: 21599008
[TBL] [Abstract][Full Text] [Related]
8. HPMA copolymer-cyclic RGD conjugates for tumor targeting.
Pike DB; Ghandehari H
Adv Drug Deliv Rev; 2010 Feb; 62(2):167-83. PubMed ID: 19951733
[TBL] [Abstract][Full Text] [Related]
9. Tumor-targeted HPMA copolymer-(RGDfK)-(CHX-A''-DTPA) conjugates show increased kidney accumulation.
Borgman MP; Coleman T; Kolhatkar RB; Geyser-Stoops S; Line BR; Ghandehari H
J Control Release; 2008 Dec; 132(3):193-9. PubMed ID: 18687371
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive monitoring of HPMA copolymer-RGDfK conjugates by magnetic resonance imaging.
Zarabi B; Borgman MP; Zhuo J; Gullapalli R; Ghandehari H
Pharm Res; 2009 May; 26(5):1121-9. PubMed ID: 19160028
[TBL] [Abstract][Full Text] [Related]
11. Synergistic enhancement of cancer therapy using a combination of heat shock protein targeted HPMA copolymer-drug conjugates and gold nanorod induced hyperthermia.
Larson N; Gormley A; Frazier N; Ghandehari H
J Control Release; 2013 Aug; 170(1):41-50. PubMed ID: 23602864
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor angiogenic vasculature using polymer-RGD conjugates.
Mitra A; Mulholland J; Nan A; McNeill E; Ghandehari H; Line BR
J Control Release; 2005 Jan; 102(1):191-201. PubMed ID: 15653145
[TBL] [Abstract][Full Text] [Related]
13. In vitro synergistic action of geldanamycin- and docetaxel-containing HPMA copolymer-RGDfK conjugates against ovarian cancer.
Larson N; Roberts S; Ray A; Buckway B; Cheney DL; Ghandehari H
Macromol Biosci; 2014 Dec; 14(12):1735-47. PubMed ID: 25185891
[TBL] [Abstract][Full Text] [Related]
14. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R
Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates.
Kasuya Y; Lu ZR; Kopecková P; Minko T; Tabibi SE; Kopecek J
J Control Release; 2001 Jul; 74(1-3):203-11. PubMed ID: 11489496
[TBL] [Abstract][Full Text] [Related]
16. Gold nanorod-mediated hyperthermia enhances the efficacy of HPMA copolymer-90Y conjugates in treatment of prostate tumors.
Buckway B; Frazier N; Gormley AJ; Ray A; Ghandehari H
Nucl Med Biol; 2014 Mar; 41(3):282-9. PubMed ID: 24461626
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments.
Shiah JG; Sun Y; Peterson CM; Straight RC; Kopecek J
Clin Cancer Res; 2000 Mar; 6(3):1008-15. PubMed ID: 10741728
[TBL] [Abstract][Full Text] [Related]
18. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.
Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257
[TBL] [Abstract][Full Text] [Related]
19. A prostate-specific antigen activated N-(2-hydroxypropyl) methacrylamide copolymer prodrug as dual-targeted therapy for prostate cancer.
Chandran SS; Nan A; Rosen DM; Ghandehari H; Denmeade SR
Mol Cancer Ther; 2007 Nov; 6(11):2928-37. PubMed ID: 18025277
[TBL] [Abstract][Full Text] [Related]
20. The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia.
Tomalova B; Sirova M; Rossmann P; Pola R; Strohalm J; Chytil P; Cerny V; Tomala J; Kabesova M; Rihova B; Ulbrich K; Etrych T; Kovar M
J Control Release; 2016 Feb; 223():1-10. PubMed ID: 26708020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]